Title:
RNAでの幹細胞分化による膵臓β細胞の誘導
Document Type and Number:
Japanese Patent JP7125394
Kind Code:
B2
Abstract:
A novel method of inducing or producing pancreatic beta cells from human induced pluripotent stem cells at an unprecedented efficiency and functionality. The core of the invention is the use of experimentally discovered mRNAs at multiple critical differentiation decision points along a pluripotent to mesendoderm to endoderm to pancreatic endocrine cells to pancreatic beta cells pathway in a previously unknown manner.
More Like This:
Inventors:
Wang Zi Wu
Nee, Yuhui
Zhao, Yuanyuan
Nee, Yuhui
Zhao, Yuanyuan
Application Number:
JP2019525968A
Publication Date:
August 24, 2022
Filing Date:
November 16, 2017
Export Citation:
Assignee:
Aryl Biotechnology and Pharmaceuticals, Incorporated
International Classes:
C12N5/10; A61K35/39; A61L27/38; A61P3/10
Foreign References:
US20120207744 | ||||
WO2015178397A1 | ||||
WO2016134313A1 |
Other References:
Clin Exp Med,2015年,Vol.15,P.501-509
Differentiation,2014年,Vol.87,P.200-208
STEM CELLS TRANSLATIONAL MEDICINE,2016年,Vol.5,P.1525-1537
Differentiation,2014年,Vol.87,P.200-208
STEM CELLS TRANSLATIONAL MEDICINE,2016年,Vol.5,P.1525-1537
Attorney, Agent or Firm:
Shusaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Previous Patent: Container with improved resealable cover member
Next Patent: TENSION MECHANISM FOR MULTI-COLOR INK RIBBON CASSETTE
Next Patent: TENSION MECHANISM FOR MULTI-COLOR INK RIBBON CASSETTE